Found 7 matching trials
To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
PHASE2This study will investigate the Safety and Tolerability of Repeated Subcuta...
Location
ATP Clinical Research, Inc.
To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
PHASE2This study will evaluate the safety and tolerability of repeated subcutaneo...
Location
Novartis Investigative Site
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
PHASE1This study will evaluate the safety and tolerability and Aß-specific antibo...
Location
Novartis Investigative Site
Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
PHASE2This study will evaluate the safety and tolerability of repeated subcutaneo...
Location
Centre Hospitalier Universitaire Pellegrin
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
PHASE2This study will assess the safety, tolerability and Abeta-specific antibody...
Location
Novartis Investigative Site
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
PHASE2The purpose of this study was to test whether two investigational drugs cal...
Location
Banner Alzheimer's Institute
Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
PHASE2This study will evaluate the safety and tolerability of repeated subcutaneo...
Location
ATP Clinical Research